Resecable Esophageal or Gastroesophageal Junction Cancer

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Resecable Esophageal or Gastroesophageal Junction Cancer trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingNot Applicable

NCT06649474

Evaluation, in Humans, of the Correlation Between Hepatotoxicity, Neurotoxicity Induced by Oxaliplatin, and Blood Levels…

Oesogastric and pancreatic adenocarcinomas are poor-prognosis cancers. Incidence of pancreatic cancer drastically increases to such an extent that it will becom…

France100 participantsStarted 2024-09-06

Treatment: assess the serum HMGB1 concentrations before and after an oxaliplatin-based chemotherapy

All recent trials (2 shown)

Not Yet RecruitingNot Applicable

NCT07408999

Totally Versus Hybrid Minimally Invasive Esophagectomy for Esophageal Cancer

Esophageal and gastroesophageal junction cancers remain associated with poor survival despite progress in multimodal treatment. Surgery, especially Ivor-Lewis e…

France327 participantsStarted 2026-03-31

Treatment: Totally Minimally Invasive Esophagectomy (TMIE), Hybrid Esophagectomy (HE)